Janel (JANL) Quality Rank

View and export this data going back to . Start your Free Trial

What is Janel Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:

Interest coverage
Zscore
Debt to revenue
Equity to asset
Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:

Operating margin mean rank (10-year mean average profit margine)
Operating margin growth rank
Fscore
Predictability rank
Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
Num of year profit (number of years that is profitable within the last 10 years)
ROIC median (10-year median of ROIC)

Janel Quality Rank Related Terms

Thank you for viewing the detailed overview of Janel's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Janel (JANL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » Janel Corp (OTCPK:JANL) » Definitions » Quality Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

80 Eighth Avenue, New York, NY, USA, 10011

Website

https://www.janelcorp.com

Janel Corp is a holding company. The company's operating segments include Logistics Services, Manufacturing, and Life Sciences. The logistics Services segment is a full-service provider of cargo transportation logistics management services, including freight forwarding via air, ocean, and land-based carriers, customs brokerage services, warehousing, and distribution services. The Manufacturing segment is engaged in manufacturing and distributing industrial mixing equipment and apparatus for specific applications within various industries. The Life Sciences segment manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents, and other immunoreagents for biomedical research. It generates maximum revenue from the Logistics Services segment.

Executives

Kesteren Gerard Van	director	80 EIGHTH AVENUE, NEW YORK NY 10011
Gregory B Graves	director	129 CONCORD ROAD, BILLERICA MA 01821
Dominique Schulte	10 percent owner	68 BANK STREET, NEW YORK NY 10014
Brendan James Killackey	director	80 EIGHTH AVENUE, NEW YORK NY 10011
Oaxaca Group L.l.c.	10 percent owner	68 BANK STREET, NEW YORK NY 10014
Vincent Verde	officer: CFO	C/O JANEL CORPORATION, 303 MERRICK ROAD, SUITE 400, LYNBROOK NY 11563
Ryan Karen Miller	director	2260 S ADAMS, DENVER CO 80210
John Eidinger	10 percent owner	80 EIGHTH AVENUE, NEW YORK NY 10011
Gonzalez John Joseph Ii	10 percent owner, officer: SR Managing Director NE Region	7 PARSONS LANDING, ISLIP NY 11751
Gregory J Melsen	director	614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413
James N Jannello	10 percent owner	303 MERRICK ROAD - SUITE 200, LYNBROOK NY 11563
Carlos Pla	officer: CFO	303 MERRICK ROAD, SUITE 400, LYNBROOK NY 11563
Brian Aronson	officer: CFO	745 BOULEVARD EAST, WEEHAWKEN NJ 07086
Nicholas V Ferrara	director	303 MERRICK ROAD - SUITE 200, LYNBROOK NY 11563
Philip J Dubato	officer: EVP of Finance	303 MERRICK ROAD - SUITE 200, LYNBROOK NY 11563